In this episode of Breast Cancer Conversations, host Laura Carfang speaks with Dr. Dehdashti, a board-certified nuclear medicine expert and senior vice chair at the Washington University Mallinckrodt Institute of Radiology. Dr. Dehdashti discusses her decades of experience in translational PET research and interpreting PET imaging studies, with a focus on receptor imaging in breast cancer. She shares her experience designing and executing clinical trials, including the first human use of the novel radiotracer Cerianna. This episode provides valuable insight into the field of nuclear medicine and its applications in oncology.

Topics Covered Include:
[00:01:20] Receptor Imaging in Breast Cancer.
[00:06:01] Developing estrogen receptor imaging agents.
[00:09:18] PET imaging in breast cancer.
[00:13:51] FES and breast cancer treatment.
[00:18:06] Functional Estrogen Receptors.
[00:23:11] Patient involvement in research.

++++++++++++++++++++++++++++++++++
About SurvivingBreastCancer.org.

Survivingbreastcancer.org (SBC) was created in 2017 to help fill the gaps in breast cancer support, education, and resources. It was founded by Laura Carfang, who was recently diagnosed at that time in her early 30’s. Since 2017, SBC has grown exponentially, serving members in the global breast cancer community. Over these past few years, the SBC website has been visited by community members (over 1,000,000 page views) across 120+ plus countries, and Laura’s podcast, Breast Cancer Conversations has been listened to in over 80 countries.

Leveraging technology and breaking down barriers to access and information, SBC puts the patient first, educating, encouraging and inspiring advocacy. Community members are encouraged to participate in the various free programming, events and services and are all invited to contribute to resolving the growing needs of this population.

Website:
https://www.survivingbreastcancer.org/

Donate Now
Please consider making a donation.
https://www.survivingbreastcancer.org/donate-now

Support the show

Get the future of podcasts.